335 related articles for article (PubMed ID: 8559487)
1. Atherogenic lipid profile and lipoprotein(a) in relation to serum albumin in haemodialysis patients.
Yang WS; Kim SB; Min WK; Park S; Lee MS; Park JS
Nephrol Dial Transplant; 1995; 10(9):1668-71. PubMed ID: 8559487
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome.
Hu P; Lu L; Hu B; Du PF
Scand J Clin Lab Invest; 2009; 69(6):680-6. PubMed ID: 19468931
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk factors in hemodialysis and peritoneal dialysis patients.
Helal I; Smaoui W; Hamida FB; Ouniss M; Aderrahim E; Hedri H; Elyounsi F; Maiz HB; Abdallah TB; Kheder A
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):59-62. PubMed ID: 20061694
[TBL] [Abstract][Full Text] [Related]
4. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
5. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
[TBL] [Abstract][Full Text] [Related]
6. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
7. Assessment of lipid dysfunction in patients on maintenance haemodialysis.
Altaf A; Halim A; Khan DA; Khalid M; Fatima-Tuz-Zuhra ; Saif I
J Ayub Med Coll Abbottabad; 2007; 19(4):32-6. PubMed ID: 18693593
[TBL] [Abstract][Full Text] [Related]
8. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone therapy and lipid profile in children on chronic peritoneal dialysis.
Jedrzejowski A; Pańczyk-Tomaszewska M; Roszkowska-Blaim M; Lis D; Gałazka B; Dyras P
Pediatr Nephrol; 2002 Oct; 17(10):830-6. PubMed ID: 12376812
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.
Ansari MR; Maheshwari N; Shaikh MA; Laghari MS; ; Lal K; Ahmed K
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):21-5. PubMed ID: 22237213
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
Bossola M; Giungi S; Panocchia N; Vulpio C; Luciani G; Tazza L
J Nephrol; 2008; 21(2):197-204. PubMed ID: 18446714
[TBL] [Abstract][Full Text] [Related]
12. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
13. Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.
Fernández E; Betriu MA; Gómez R; Montoliu J
Nephrol Dial Transplant; 1996 Aug; 11(8):1559-63. PubMed ID: 8856211
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
[TBL] [Abstract][Full Text] [Related]
15. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
[TBL] [Abstract][Full Text] [Related]
16. Malnutrition, inflammation, and lipids in a cohort of dialysis patients.
Bowden RG; Wilson RL
Postgrad Med; 2010 May; 122(3):196-202. PubMed ID: 20463430
[TBL] [Abstract][Full Text] [Related]
17. Does ingestion of regular coffee influence serum lipid profile in dialysis patients?
Grzegorzewska AE; Młot-Michalska M; Wobszal P
Adv Perit Dial; 2009; 25():181-6. PubMed ID: 19886342
[TBL] [Abstract][Full Text] [Related]
18. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
19. Is an elevated level of serum lipoprotein (a) a risk factor for cardiovascular disease in CAPD patients?
Avram MM; Sreedhara R; Patel N; Chattopadhyay J; Thu T; Fein P
Adv Perit Dial; 1996; 12():266-71. PubMed ID: 8865917
[TBL] [Abstract][Full Text] [Related]
20. The association of lipid levels with mortality in patients on chronic peritoneal dialysis.
Habib AN; Baird BC; Leypoldt JK; Cheung AK; Goldfarb-Rumyantzev AS
Nephrol Dial Transplant; 2006 Oct; 21(10):2881-92. PubMed ID: 16735386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]